Clinical
trials are the cornerstone of medical innovation. Every breakthrough therapy,
vaccine, or medical device reaches patients only after successfully navigating
a rigorous clinical development process.
Yet,
despite significant scientific advances, nearly 90% of drug candidates entering
clinical development never reach the market. While scientific efficacy is one
challenge, many clinical trials fail due to operational, regulatory, and
strategic issues that are often preventable.
Understanding
these challenges is the first step towards designing more successful clinical
development programmes.
1. Poor
Study Design
A trial
begins with its protocol. Ambiguous eligibility criteria, unrealistic
endpoints, or an overly complex study design can compromise recruitment,
increase protocol deviations, and ultimately affect study outcomes.
Key
takeaway: A scientifically robust and operationally feasible
protocol is essential.
2. Slow
Patient Recruitment
One of the
most common reasons for trial delays is inadequate patient enrolment.
Overestimating eligible participants, selecting unsuitable sites, or failing to
engage patients effectively can significantly prolong timelines.
Key
takeaway: Patient-centric recruitment strategies and careful
site selection are critical.
3. Poor
Data Quality
Incomplete
documentation, protocol deviations, inconsistent source data, and delayed data
entry can jeopardise the integrity of a study and complicate regulatory
submissions.
Key
takeaway: High-quality data is the foundation of credible
clinical evidence.
4.
Inadequate Project Management
Clinical
trials involve multiple stakeholders—including sponsors, CROs, investigators,
vendors, laboratories, and regulatory teams. Without effective coordination,
communication gaps and timeline delays become inevitable.
Key
takeaway: Strong project management keeps studies on schedule
and aligned with their objectives.
5.
Regulatory Delays
Delays in
ethics committee approvals, regulatory submissions, protocol amendments, or
documentation can significantly impact study initiation and completion.
Key
takeaway: Early regulatory planning reduces avoidable delays.
6.
Inefficient Site Selection
Selecting
sites without considering recruitment capability, investigator experience,
infrastructure, or patient availability often leads to underperforming sites
and prolonged enrolment.
Key
takeaway: Site feasibility should extend beyond geographic
location—it must evaluate operational readiness.
7. Budget
Constraints and Resource Limitations
Unexpected
costs, insufficient staffing, or limited operational resources can disrupt
study conduct and affect data quality.
Key
takeaway: Realistic budgeting and proactive resource planning
are essential for successful execution.
8. Poor
Risk Management
Many
challenges in clinical research can be anticipated. Organisations that lack
structured risk identification and mitigation plans often struggle when issues
arise.
Key
takeaway: Proactive risk management should be embedded
throughout the study lifecycle.
9.
Communication Gaps
Successful
trials depend on continuous collaboration among sponsors, CROs, investigators,
vendors, and project teams. Miscommunication can lead to delays, duplicated
efforts, and operational inefficiencies.
Key
takeaway: Clear governance and transparent communication
strengthen study execution.
10. Lack of
Flexibility
Clinical
research is dynamic. Recruitment challenges, protocol amendments, emerging
safety data, and operational changes require teams to adapt quickly while
maintaining compliance.
Key
takeaway: Agile, responsive teams are better equipped to manage
change without compromising quality.